[go: up one dir, main page]

WO2003010541A1 - Procede d'analyse par immunoreaction, et reactif correspondant - Google Patents

Procede d'analyse par immunoreaction, et reactif correspondant Download PDF

Info

Publication number
WO2003010541A1
WO2003010541A1 PCT/JP2002/005568 JP0205568W WO03010541A1 WO 2003010541 A1 WO2003010541 A1 WO 2003010541A1 JP 0205568 W JP0205568 W JP 0205568W WO 03010541 A1 WO03010541 A1 WO 03010541A1
Authority
WO
WIPO (PCT)
Prior art keywords
substance
reagent
immunoreaction
assay
detected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2002/005568
Other languages
English (en)
French (fr)
Inventor
Akihito Kamei
Noriko Kenjo
Tatsuro Kawamura
Mahito Hirai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Holdings Corp
Original Assignee
Matsushita Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Industrial Co Ltd filed Critical Matsushita Electric Industrial Co Ltd
Priority to DE60213984T priority Critical patent/DE60213984T2/de
Priority to EP02733326A priority patent/EP1396724B1/en
Priority to KR1020037002112A priority patent/KR100549360B1/ko
Publication of WO2003010541A1 publication Critical patent/WO2003010541A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
PCT/JP2002/005568 2001-06-14 2002-06-05 Procede d'analyse par immunoreaction, et reactif correspondant Ceased WO2003010541A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE60213984T DE60213984T2 (de) 2001-06-14 2002-06-05 Test-verfahren durch immunoreaktion und reaktionsmittel zur verwendung bei einem immunoreaktionstest
EP02733326A EP1396724B1 (en) 2001-06-14 2002-06-05 Method of assay by immunoreaction and reagent for use in the immunoreaction assay
KR1020037002112A KR100549360B1 (ko) 2001-06-14 2002-06-05 면역반응 측정 방법 및 이에 사용하는 면역반응 측정용 시약

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001179710 2001-06-14
JP2001-179710 2001-06-14
JP2001368286A JP2003066047A (ja) 2001-06-14 2001-12-03 免疫反応測定方法及びそれに用いる免疫反応測定用試薬
JP2001-368286 2001-12-03

Publications (1)

Publication Number Publication Date
WO2003010541A1 true WO2003010541A1 (fr) 2003-02-06

Family

ID=26616877

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/005568 Ceased WO2003010541A1 (fr) 2001-06-14 2002-06-05 Procede d'analyse par immunoreaction, et reactif correspondant

Country Status (7)

Country Link
US (1) US20030180806A1 (ja)
EP (1) EP1396724B1 (ja)
JP (1) JP2003066047A (ja)
KR (1) KR100549360B1 (ja)
CN (1) CN1258089C (ja)
DE (1) DE60213984T2 (ja)
WO (1) WO2003010541A1 (ja)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US8992908B2 (en) 2010-11-23 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of oral mucositis
US8999330B2 (en) 2007-05-21 2015-04-07 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US9085615B2 (en) 2008-11-25 2015-07-21 Alderbio Holdings Llc Antibodies to IL-6 to inhibit or treat inflammation
US9187560B2 (en) 2008-11-25 2015-11-17 Alderbio Holdings Llc Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US9241990B2 (en) 2007-05-21 2016-01-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRIP
US9265825B2 (en) 2008-11-25 2016-02-23 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US9468676B2 (en) 2009-11-24 2016-10-18 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US9546213B2 (en) 2007-05-21 2017-01-17 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US9725509B2 (en) 2007-05-21 2017-08-08 Alderbio Holdings Llc Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibody
US9771421B2 (en) 2007-05-21 2017-09-26 Alderbio Holdings Llc Treating anemia in chronic IL-6 associated diseases using anti-IL-6 antibodies
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
US9834603B2 (en) 2007-05-21 2017-12-05 Alderbio Holdings Llc Antibodies to IL-6 and use thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2005031353A1 (ja) * 2003-09-26 2006-12-07 松下電器産業株式会社 免疫反応測定方法、ならびにそれに用いる試薬、キット、及び光学セル
CN101065671A (zh) * 2004-11-25 2007-10-31 松下电器产业株式会社 传感器装置
DK2095126T3 (da) * 2006-12-15 2010-05-10 Biotrin Intellectual Pty Ltd Fremgangsmåde til påvisning af humant parvovirusantigen
KR20110091781A (ko) * 2008-11-25 2011-08-12 앨더 바이오파마슈티컬즈, 인코포레이티드 혈전증을 예방하거나 치료하기 위한 ｉｌ­６의 길항제
WO2013108168A2 (en) * 2012-01-16 2013-07-25 Koninklijke Philips N.V. Determining a presence of target molecules in a body fluid comprising cells
CN118443922A (zh) * 2016-09-06 2024-08-06 富士瑞必欧株式会社 肿瘤标记物的测定方法及测定试剂
CN110618263B (zh) * 2018-06-20 2021-10-29 厦门万泰凯瑞生物技术有限公司 一种c反应蛋白全程检测的方法以及相应的试剂盒
TWI842764B (zh) 2018-11-09 2024-05-21 日商積水醫療股份有限公司 抑制以自動分析裝置進行的免疫測定中之異常檢測的方法、檢測方法、免疫測定試劑、及免疫測定試劑套組
CN114152755A (zh) * 2021-12-06 2022-03-08 石家庄斯巴克生物科技有限公司 一种c反应蛋白检测试剂处理液、试剂盒及检测方法
CN114544978A (zh) * 2022-03-04 2022-05-27 美康生物科技股份有限公司 一种igf-1检测试剂盒及其制备方法和检测方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0236354A (ja) * 1988-07-27 1990-02-06 Snow Brand Milk Prod Co Ltd 紛末状非特異的吸着防止剤の製造方法
JPH0261561A (ja) * 1988-08-26 1990-03-01 Dai Ichi Pure Chem Co Ltd 免疫反応の測定方法
JPH0682450A (ja) * 1992-09-04 1994-03-22 Eiken Chem Co Ltd 免疫学的測定試薬
JPH07270413A (ja) * 1994-03-31 1995-10-20 Snow Brand Milk Prod Co Ltd 非特異的吸着防止剤
JPH11344494A (ja) * 1998-06-01 1999-12-14 Eiken Chem Co Ltd 免疫学的凝集反応試薬およびこれを用いたプロゾーン現象の抑制方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57182169A (en) * 1981-05-02 1982-11-09 Mitsubishi Chem Ind Ltd Measuring method for antigen-antibody reaction
JPS6057257A (ja) * 1983-09-09 1985-04-03 Hitachi Ltd イムノアツセイ法
US4931385A (en) * 1985-06-24 1990-06-05 Hygeia Sciences, Incorporated Enzyme immunoassays and immunologic reagents
GB8800702D0 (en) * 1988-01-13 1988-02-10 Nycomed As Test method & reagent kit therefor
US5272258A (en) * 1989-06-29 1993-12-21 Rush-Presbyterian-St. Luke's Medical Center Monoclonal antibodies to C-reactive protein
WO1991010911A1 (en) * 1990-01-19 1991-07-25 Repligen Corporation Immunoassay of protein a under acidic conditions
US5358852A (en) * 1992-12-21 1994-10-25 Eastman Kodak Company Use of calcium in immunoassay for measurement of C-reactive protein
US5616460A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
JP4219491B2 (ja) * 1999-06-18 2009-02-04 富士フイルム株式会社 乾式分析方法及び乾式分析要素

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0236354A (ja) * 1988-07-27 1990-02-06 Snow Brand Milk Prod Co Ltd 紛末状非特異的吸着防止剤の製造方法
JPH0261561A (ja) * 1988-08-26 1990-03-01 Dai Ichi Pure Chem Co Ltd 免疫反応の測定方法
JPH0682450A (ja) * 1992-09-04 1994-03-22 Eiken Chem Co Ltd 免疫学的測定試薬
JPH07270413A (ja) * 1994-03-31 1995-10-20 Snow Brand Milk Prod Co Ltd 非特異的吸着防止剤
JPH11344494A (ja) * 1998-06-01 1999-12-14 Eiken Chem Co Ltd 免疫学的凝集反応試薬およびこれを用いたプロゾーン現象の抑制方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1396724A4 *

Cited By (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9758579B2 (en) 2007-05-21 2017-09-12 Alder Bioholdings, Llc Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity
US10759853B2 (en) 2007-05-21 2020-09-01 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US8999330B2 (en) 2007-05-21 2015-04-07 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US10344086B2 (en) 2007-05-21 2019-07-09 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US10233239B2 (en) 2007-05-21 2019-03-19 Alderbio Holdings Llc Isolated host cells expressing anti-IL-6 antibodies
US10160804B2 (en) 2007-05-21 2018-12-25 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US9241990B2 (en) 2007-05-21 2016-01-26 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRIP
US10040851B2 (en) 2007-05-21 2018-08-07 Alderbio Holdings Llc Antagonists to IL-6 to raise albumin and/or lower CRP
US10913794B2 (en) 2007-05-21 2021-02-09 Vitaeris Inc. Antibodies to IL-6 and use thereof
US10787507B2 (en) 2007-05-21 2020-09-29 Vitaeris Inc. Antagonists of IL-6 to prevent or treat thrombosis
US9771421B2 (en) 2007-05-21 2017-09-26 Alderbio Holdings Llc Treating anemia in chronic IL-6 associated diseases using anti-IL-6 antibodies
US9546213B2 (en) 2007-05-21 2017-01-17 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US9701747B2 (en) 2007-05-21 2017-07-11 Alderbio Holdings Llc Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
US9926370B2 (en) 2007-05-21 2018-03-27 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US10800841B2 (en) 2007-05-21 2020-10-13 Vitaeris, Inc. Methods of treating autoimmunity using specific anti-IL-6 antibodies
US9725509B2 (en) 2007-05-21 2017-08-08 Alderbio Holdings Llc Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibody
US11827700B2 (en) 2007-05-21 2023-11-28 Vitaeris Inc. Treatment or prevention of diseases and disorders associated with cells that express IL-6 with Anti-IL-6 antibodies
US9884912B2 (en) 2007-05-21 2018-02-06 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US9834603B2 (en) 2007-05-21 2017-12-05 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US9452227B2 (en) 2008-11-25 2016-09-27 Alderbio Holdings Llc Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
US10787511B2 (en) 2008-11-25 2020-09-29 Vitaeris Inc. Antagonists of IL-6 to raise albumin and/or lower CRP
US8992920B2 (en) 2008-11-25 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US9879074B2 (en) 2008-11-25 2018-01-30 Alderbio Holdings Llc Antibodies to IL-6 and use thereof
US9765138B2 (en) 2008-11-25 2017-09-19 Alderbio Holdings Llc Isolated anti-IL-6 antibodies
US10858424B2 (en) 2008-11-25 2020-12-08 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of arthritis
US10640560B2 (en) 2008-11-25 2020-05-05 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or fever
US9994635B2 (en) 2008-11-25 2018-06-12 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US9265825B2 (en) 2008-11-25 2016-02-23 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US10053506B2 (en) 2008-11-25 2018-08-21 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
US10117955B2 (en) 2008-11-25 2018-11-06 Alderbio Holdings Llc Methods of aiding in the diagnosis of diseases using anti-IL-6 antibodies
US9212223B2 (en) 2008-11-25 2015-12-15 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US9187560B2 (en) 2008-11-25 2015-11-17 Alderbio Holdings Llc Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever
US9085615B2 (en) 2008-11-25 2015-07-21 Alderbio Holdings Llc Antibodies to IL-6 to inhibit or treat inflammation
US10391169B2 (en) 2009-07-28 2019-08-27 Alderbio Holdings Llc Method of treating allergic asthma with antibodies to IL-6
US9468676B2 (en) 2009-11-24 2016-10-18 Alderbio Holdings Llc Antagonists of IL-6 to prevent or treat thrombosis
US10471143B2 (en) 2009-11-24 2019-11-12 Alderbio Holdings Llc Antagonists of IL-6 to raise albumin and/or lower CRP
US9821057B2 (en) 2009-11-24 2017-11-21 Alderbio Holdings Llc Anti-IL-6 antibody for use in the treatment of cachexia
US9775921B2 (en) 2009-11-24 2017-10-03 Alderbio Holdings Llc Subcutaneously administrable composition containing anti-IL-6 antibody
US9724410B2 (en) 2009-11-24 2017-08-08 Alderbio Holdings Llc Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity
US9717793B2 (en) 2009-11-24 2017-08-01 Alderbio Holdings Llc Method of improving patient survivability and quality of life by administering an anti-IL-6 antibody
US9957321B2 (en) 2010-11-23 2018-05-01 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of oral mucositis
US9304134B2 (en) 2010-11-23 2016-04-05 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of anemia
US8992908B2 (en) 2010-11-23 2015-03-31 Alderbio Holdings Llc Anti-IL-6 antibodies for the treatment of oral mucositis

Also Published As

Publication number Publication date
KR100549360B1 (ko) 2006-02-08
JP2003066047A (ja) 2003-03-05
US20030180806A1 (en) 2003-09-25
EP1396724B1 (en) 2006-08-16
CN1258089C (zh) 2006-05-31
DE60213984T2 (de) 2007-01-25
EP1396724A1 (en) 2004-03-10
EP1396724A4 (en) 2004-07-14
DE60213984D1 (de) 2006-09-28
CN1463364A (zh) 2003-12-24
KR20030031153A (ko) 2003-04-18

Similar Documents

Publication Publication Date Title
WO2003010541A1 (fr) Procede d'analyse par immunoreaction, et reactif correspondant
WO2007011936A3 (en) Lateral flow assay and device using magnetic particles
WO2002037108A8 (fr) Reactif et procede permettant de detecter une substance
CA2188752A1 (en) Immunoassay for homocysteine
CA2250242A1 (en) Quantitative immunochromatographic assays
EP1033575A3 (en) Device for carrying out lateral-flow assays involving more than one analyte
EP1281968A3 (en) Assay using porosity-reduction to inhibit migration
WO2003023051A3 (en) Lateral flow test format for enzyme assays
KR20240059633A (ko) 고농도의 분석물을 포함한 분석물을 측정하기 위한 용량 반응 곡선의 신호 부분을 감소시키는 단계를 사용하는 샌드위치-유형 분석법
CN108333344A (zh) 高灵敏度的化学发光免疫分析试剂盒及其制备方法和应用
WO2001040755A3 (en) A novel and practical serological assay for the clinical diagnosis of leishmaniasis
WO2007063326A3 (en) Assay device and method
ATE274699T1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
EP1083428A3 (en) Method and reagent for the detection or determination of HCV core antigens
WO2003054225A3 (de) Verfahren zur bestimmung von nukleinsäureanalyten
EP0346119A3 (en) Anti-fc assay for detection of antibodies
TW200745547A (en) Kit for assaying active ingredient of termite controlling agent by using immunoassay method
WO2005073405A3 (en) Catalytic polynucleotide and its use for determination of analytes
WO2001059156A3 (en) DETECTION OF BINDING OF CHARGED SPECIES USING pH- OR POTENTIAL-SENSITIVE PROBES
WO2003038436A3 (en) Microfluidic ser(r)s detection
WO1999067642A3 (en) Method of detecting an antibody in a liquid sample
WO2000034790A3 (de) Verfahren zum nachweis von antikörpern oder antigenen sowie zur blutgruppenbestimmung
HK1040112A1 (zh) 在液体样本中检测和/或定量特异ige抗体的方法
ATE354090T1 (de) Verfahren zum bestimmen von crp mit hilfe von phosphorylcholin
WO2006071970A3 (en) Methods for the detection of analytes in a sample

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 10311775

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002733326

Country of ref document: EP

AK Designated states

Kind code of ref document: A1

Designated state(s): CN KR US

Kind code of ref document: A1

Designated state(s): CN KR

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB IE IT LU MC NL PT SE TR

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 1020037002112

Country of ref document: KR

Ref document number: 028020820

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWP Wipo information: published in national office

Ref document number: 1020037002112

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2002733326

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1020037002112

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 2002733326

Country of ref document: EP